Psychedelics, With a Focus on Psilocybin: Issues for the Clinician.
Journal of Psychiatric Practice September 1, 2023 Amir Garakani, Jeanne L Alexander, Calvin R Sumner et al. 6 citations
There has been a burgeoning interest in psychedelics among the public, state legislatures, psychiatrists and other clinical providers, and within the research community. Increasing numbers of studies evaluating psychedelics for depression, anxiety, posttraumatic stress disorder, and substance use disorders have been conducted or are underway. While discussing psychedelics in general, the focus...